MACS® GMP Recombinant Human IL-3

Interleukin 3 (IL-3) is a hematopoietic growth factor with a broad spectrum of biologic activities. These include the stimulation of the proliferation and differentiation of immature pluripotent hematopoietic stem cells and various lineage-committed progenitor cells, leading to the production of most of the major blood cell types.

MACS GMP Recombinant Human IL-3 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyoph

... read more

Related products for MACS® GMP Recombinant Human IL-3

Specifications for MACS® GMP Recombinant Human IL-3
Overview

Interleukin 3 (IL-3) is a hematopoietic growth factor with a broad spectrum of biologic activities. These include the stimulation of the proliferation and differentiation of immature pluripotent hematopoietic stem cells and various lineage-committed progenitor cells, leading to the production of most of the major blood cell types.

MACS GMP Recombinant Human IL-3 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Detailed product information

Biological activity

Determination method
The specific activity is determined by proliferation assay according to Kitamura et al.1 using TF-1 cells provided by the German Resource Centre for Biological Material (DSMZ). The proliferation assay was calibrated with the international standard for human IL-3 (NIBSC code 91/510) provided by the National Institute for Biological Standards and Control.
Minimal specific activity
≥ 1×106 IU/mg
Background information

IL-3 is mainly produced by activated T cells, but is also secreted by other cell types, including mast cells, eosinophils, and keratinocytes. Beside its role as hematopoietic growth factor, IL-3 also affects the functional activity of mature mast cells, basophils, eosinophils, and macrophages.

Applications

MACS GMP Recombinant Human IL-3 can be used for a variety of applications, including the ex vivo cultivation of human plasmacytoid dendritic cells from enriched CD304 (BDCA-4)+ cells.2–4

Technical specifications

  • Identity/ Molecular mass: 15089 Da, determined by mass spectrometry. This corresponds to the mature form of human IL-3 (133 amino acids).
  • Purity: ≥ 95 % as determined by chip electrophoresis.
  • Endotoxin content: < 50 EU/mg, as determined by kinetic Limulus Amoebocyte Lysate (LAL) assay (Pharmacopoeia Europaea (Ph. Eur.)).
  • Residual host cell DNA content: < 20 ng/mg, as determined by quantitative PCR specific for E. coli genomic DNA.
  • Residual host cell protein content: < 1 µg/mg, as determined by E. coli HCP ELISA.

The product quality certificate of our MACS® GMP Recombinant Human IL-3 has been adapted. Learn more here

Quality statement

MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

Disclaimer

MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.

Product data and images for MACS® GMP Recombinant Human IL-3
Figure 1

Mass spectrometry analysis (ESI-MS) of MACS GMP Recombinant Human IL-3. The peak corresponds to the calculated molecular mass of 15089 Da.

Figure 2

MACS GMP Recombinant Human IL-3 biological activity. Activity of Human IL-3, GMP grade, (blue bar) was compared to other commercially available products (black and grey bar).

Citations for MACS® GMP Recombinant Human IL-3
Publications
  1. Kitamura, T. et al. (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140: 323-334
  2. Grouard, G. et al. (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185: 1101-1111
  3. Colonna, M. et al. (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226
  4. Cella, M. et al. (2000) Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1: 305-310